Anna Wald MD

Professor, Medicine, Laboratory Medicine & Pathology, Epidemiology University of Washington School of Medicine, Vaccine & Infectious Diseases Division, Fred Hutch

Join to View Full Profile

325 9th AveSeattle, WA 98122
Phone+1 206-520-4340

Summary

Academic infectious diseases

Education & Training

University of WashingtonFellowship, Infectious Disease, 1991 - 1994
Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

WA State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes Start of enrollment: 2005 Apr 01
Completed
Phase 3
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons Start of enrollment: 2003 Mar 01
Completed
Phase 4
A Study of HSV Testing Among Pregnant Women Start of enrollment: 2004 Jan 01
Terminated
Not Applicable
Suppression of Oral HHV8 Shedding With Valganciclovir Start of enrollment: 2002 Dec 01
Completed
Phase 2
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission Start of enrollment: 2004 Nov 01
Completed
Phase 3
HSV-2 Shedding Resolution After Acyclovir Treatment Start of enrollment: 2007 Jun 01
Completed
Effect of HSV-2 Suppressive Therapy on Sexual Behavior Start of enrollment: 2008 Jan 01
Terminated
Phase 4
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV Start of enrollment: 2007 Dec 01
Completed
Phase 4
GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women Start of enrollment: 2009 Jan 01
Completed
Not Applicable
An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons Start of enrollment: 2010 Jan 01
Withdrawn
Not Applicable
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding Start of enrollment: 2012 Feb 01
Completed
Phase 4
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults Start of enrollment: 2013 Dec 01
Completed
Phase 1, Phase 2
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
Completed
Phase 2
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Start of enrollment: 2017 Aug 01
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

1 citations
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Tr...
Roy F Chemaly, Tali Shafat, Anna Wald, Camille N Kotton, Genovefa Papanicolaou
Clinical Infectious Diseases. 2025-01-29
Herpes-Reply.
Christine Johnston, Anna Wald
JAMA. 2025-01-28
Viral Genomic Variation and the Severity of Genital Herpes Simplex Virus-2 Infection as Quantified by Shedding Rate: A Viral Genome-Wide Association Study.
Amanda M Casto, Hoseung Song, Hong Xie, Stacy Selke, Pavitra Roychoudhury
The Journal of Infectious Diseases. 2024-12-16

Other

6 Years Later, 9-Valent HPV Vaccine's Efficacy Persists
Anna Wald, MD, NEJM Journal Watch
https://www.doximity.com/articles/cdff9ad2-4105-4bf4-824f-237e6f302064
UpToDate, Wolters Kluwer Health - 2012-12-13
USPSTF Reinforces Recommendation for Syphilis Screening During Pregnancy
Wald A, Johnston C, NEJM Journal Watch
https://www.doximity.com/articles/09e15156-a346-4f86-81fe-97c28e40864b
UpToDate, Wolters Kluwer Health - 2012-06-29
STI Rates Climb for Fourth Straight Year
Wald A, Johnston C, NEJM Journal Watch
https://www.doximity.com/articles/b89f1dc2-5b06-4539-8d24-ab0e840c0258
UpToDate, Wolters Kluwer Health - 2012-03-01
Quantifying Pregnancy Outcomes in Zika-Infected Women
Anna Wald, MD, NEJM Journal Watch
https://www.doximity.com/articles/298779f5-faa0-4b80-ac98-695bf4651a55
UpToDate, Wolters Kluwer Health - 2012-02-17
Join now to see all

Authored Content

Quantifying Pregnancy Outcomes in Zika-Infected WomenNovember 2018
STI Rates Climb for Fourth Straight YearSeptember 2018
USPSTF Reinforces Recommendation for Syphilis Screening During PregnancySeptember 2018
6 Years Later, 9-Valent HPV Vaccine's Efficacy PersistsSeptember 2017
Join now to see all

Press Mentions

Does a Measles Infection Protect Against Cancer and Heart Disease?April 8th, 2025
No Evidence of Justin Bieber’s Facial Paralysis Caused by COVID-19 VaccineJune 15th, 2022
No Evidence Justin Bieber’s Facial Paralysis Caused by COVID-19 VaccineJune 14th, 2022
Join now to see all

Grant Support

University of Washington Vaccine and Treatment Evaluation UnitUNIVERSITY OF WASHINGTON2019–2026
University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum InfectionUNIVERSITY OF WASHINGTON2019–2025
University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum InfectionUNIVERSITY OF WASHINGTON2019–2025

Anna Wald MD

Dr. Wald is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Authored Content

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.